Tal Teitz

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model”.

Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model

JCI Insight(2023)10.1172/jci.insight.171140

N/A

0DataRank · unranked

17 citations

Richard D. Lutze, Chithra K. Pushpan, Regina G. Kelmann, Huizhan Liu, M. May +4 more

ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.18.563007

N/A

0DataRank · unranked

9 citations

Matthew A. Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz +1 more

KSR1 knockout mouse model demonstrates MAPK pathway’s key role in cisplatin- and noise-induced hearing loss

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.08.566316

N/A

0DataRank · unranked

3 citations

Richard D. Lutze, Regina G. Kelmann, Daniel F. Kresock, Jordan D. Marsh, René Vielman Quevedo +3 more

Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss

Pharmaceuticals(2024)10.3390/ph17060735

N/A

0DataRank · unranked

3 citations

Matthew A. Ingersoll, Regina G. Kelmann, Tal Teitz, Richard D. Lutze

KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss

Journal of Neuroscience(2024)10.1523/jneurosci.2174-23.2024

N/A

0DataRank · unranked

9 citations

Richard D. Lutze, Regina G. Kelmann, Daniel F. Kresock, Jordan D. Marsh, René Vielman Quevedo +3 more

ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response

International Journal of Molecular Sciences(2024)10.3390/ijms25126305

N/A

0DataRank · unranked

7 citations

Matthew A. Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz +1 more

Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.06.592815

N/A

0DataRank · unranked

1 citations

Richard D. Lutze, Matthew A. Ingersoll, Regina G. Kelmann, K.H. Ly, Duane Currier +4 more

FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.20.595056

N/A

0DataRank · unranked

0 citations

Matthew A. Ingersoll, Regina G. Kelmann, Tal Teitz, Richard D. Lutze

Oral AZD5438 is a clinically translatable otoprotectant against cisplatin-induced hearing loss

Neoplasia(2025)10.1016/j.neo.2025.101250

N/A

0DataRank · unranked

0 citations

Xintian Zhang, Enrick Vesanes, Tal Teitz, Jian Zuo, Yunlong Huang